Literature DB >> 16087194

The effect of six different statins on the proliferation, migration, and invasion of human smooth muscle cells.

J-M Corpataux1, J Naik, K E Porter, N J M London.   

Abstract

Intimal hyperplasia (IH) can occur after any vascular injury and results from smooth muscle cells (SMC) proliferation, migration, and invasion into the subintimal space. The purpose of this study was to investigate the effect of six different statins on the proliferation, migration, and invasion of human venous SMC. The statins were all used at their Cmax concentrations. SMCs were used to construct growth curves in the presence of 10% fetal calf serum or 10% fetal calf serum supplemented with the six statins. Migration and invasion experiments were performed using modified Boyden chambers. The invasion experiments were performed using Matrigel coated plates. We found that all of the statins significantly inhibited SMC proliferation compared to the platelet-derived growth factor control (ranging from fluvastatin 33% of control to pravastatin 72% of control, P = 0.03). SMC migration through uncoated polycarbonate membranes in presence of the six statins was significantly reduced (ranging from lovastatin 43% to pravastatin 57% of control, P = 0.006). All six statins also significantly reduced SMC invasion (ranging from fluvastatin 65% to simvastatin 87% of control, P = 0.002). We conclude that the inhibitory effect of statins on SMC proliferation, migration, and invasion is a class, rather than drug specific effect.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16087194     DOI: 10.1016/j.jss.2005.05.016

Source DB:  PubMed          Journal:  J Surg Res        ISSN: 0022-4804            Impact factor:   2.192


  11 in total

1.  Lipophilic statins inhibit growth and reduce invasiveness of human endometrial stromal cells.

Authors:  Anna Sokalska; Amanda B Hawkins; Toshia Yamaguchi; Antoni J Duleba
Journal:  J Assist Reprod Genet       Date:  2018-12-15       Impact factor: 3.412

2.  Lovastatin induces VSMC differentiation through inhibition of Rheb and mTOR.

Authors:  Robert J Wagner; Kathleen A Martin; Richard J Powell; Eva M Rzucidlo
Journal:  Am J Physiol Cell Physiol       Date:  2010-04-07       Impact factor: 4.249

Review 3.  Targeting the airway smooth muscle for asthma treatment.

Authors:  Blanca Camoretti-Mercado
Journal:  Transl Res       Date:  2009-07-14       Impact factor: 7.012

4.  Inhibitory effects of NO-fluvastatin on proliferation of human lens epithelial cells in vitro by modulating cell cycle regulatory proteins.

Authors:  Zhi Wang; Ruiying Gao; Qianqian Shi; Yukan Huang; Wen Chen; Kaiying Shi
Journal:  J Huazhong Univ Sci Technolog Med Sci       Date:  2008-10-10

5.  Renal and liver tumors in Tsc2(+/-) mice, a model of tuberous sclerosis complex, do not respond to treatment with atorvastatin, a 3-hydroxy-3-methylglutaryl coenzyme A reductase inhibitor.

Authors:  Geraldine A Finlay; Amy J Malhowski; Kristen Polizzi; Izabela Malinowska-Kolodziej; David J Kwiatkowski
Journal:  Mol Cancer Ther       Date:  2009-07-07       Impact factor: 6.261

Review 6.  Nonhuman Primates and Translational Research-Cardiovascular Disease.

Authors:  Laura A Cox; Michael Olivier; Kimberly Spradling-Reeves; Genesio M Karere; Anthony G Comuzzie; John L VandeBerg
Journal:  ILAR J       Date:  2017-12-01

7.  Connexin43 Inhibition Prevents Human Vein Grafts Intimal Hyperplasia.

Authors:  Alban Longchamp; Florent Allagnat; Florian Alonso; Christopher Kuppler; Céline Dubuis; Charles-Keith Ozaki; James R Mitchell; Scott Berceli; Jean-Marc Corpataux; Sébastien Déglise; Jacques-Antoine Haefliger
Journal:  PLoS One       Date:  2015-09-23       Impact factor: 3.240

8.  The anti-tubercular activity of simvastatin is mediated by cholesterol-driven autophagy via the AMPK-mTORC1-TFEB axis.

Authors:  Natalie Bruiners; Noton K Dutta; Valentina Guerrini; Hugh Salamon; Ken D Yamaguchi; Petros C Karakousis; Maria L Gennaro
Journal:  J Lipid Res       Date:  2020-08-26       Impact factor: 5.922

Review 9.  Statins and blood pressure: is there an effect or not?

Authors:  Pantelis A Sarafidis; Angeliki I Kanaki; Anastasios N Lasaridis
Journal:  J Clin Hypertens (Greenwich)       Date:  2007-06       Impact factor: 3.738

10.  Apolipoprotein(a) acts as a chemorepellent to human vascular smooth muscle cells via integrin αVβ3 and RhoA/ROCK-mediated mechanisms.

Authors:  Kirsten Riches; Larissa Franklin; Azhar Maqbool; Michelle Peckham; Matthew Adams; Jacquelyn Bond; Philip Warburton; Nicole T Feric; Marlys L Koschinsky; David J O'Regan; Stephen G Ball; Neil A Turner; Karen E Porter
Journal:  Int J Biochem Cell Biol       Date:  2013-05-31       Impact factor: 5.085

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.